New cancer education program aims to boost screening in latino communities
NCT ID NCT05832177
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a Spanish-language cancer education program called Cancer 101 in Florida and Puerto Rico. The goal is to improve cancer awareness, screening, and research participation among Spanish-speaking adults. Up to 1,200 participants will take online modules and attend community events. The study measures knowledge gains and program engagement, not direct health outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cancer 101 education program
- What this could lead to
- If successful, this could increase cancer awareness and screening rates in underserved Spanish-speaking communities.
- What could go wrong
- This is an educational outreach study, not a treatment trial. It measures knowledge and participation, not health outcomes, so direct impact on cancer rates is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2023
- Expected to finish
-
Jul 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Community members who are physicians, nurses, psychologists, community health educators, and clinical social workers
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or older * Any health status * Able to speak, read and write Spanish or English (some events are in Spanish, some are in English) * \[Cancer 101 Online Training Program, Lunch and Learn podcast, and Stakeholders Program only\]: Have access to the internet * Willing to complete the training modules and assessments \[Cancer 101 Online Training Program\] * Willing to complete registration, attendance logs, and evaluations, as applicable * \[Community Engagement Training Program, Research Corner only\]: be a researcher who received U54 funding in the proposed renewal period including Full, Pilot, and Developmental projects. * \[Stakeholders in the Community-based Training Program and Cancer 101 Stakeholders program only\]: nurses, community health educators, clinical social workers, physicians, psychologists, among other healthcare professionals Exclusion Criteria: * Does not meet inclusion criteria
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer education are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites in 2 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
Ponce Health Sciences University
RECRUITINGPonce, 00716, Puerto Rico
More trials for these conditions
Other studies related to the condition(s) this trial covers.